Boothbay Fund Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-29,600
Closed -$180K 2101
2025
Q2
$180K Hold
29,600
﹤0.01% 1261
2025
Q1
$366K Buy
+29,600
New +$419K 0.01% 978
2024
Q1
Sell
-158,800
Closed -$5.77M 1861
2023
Q4
$5.77M Buy
+158,800
New +$6.11M 0.15% 162
2022
Q4
Sell
-5,300
Closed -$321K 2369
2022
Q3
$321K Buy
+5,300
New +$168K 0.01% 1491
2019
Q4
Sell
-507
Closed -$397K 953
2019
Q3
$397K Hold
507
0.04% 513
2019
Q2
$536K Buy
+507
New +$5.21K 0.05% 393
2018
Q2
Sell
-225
Closed -$826K 864
2018
Q1
$826K Buy
+225
New +$8.18K 0.1% 210

Other funds holding PRTA

Boothbay Fund Management's PRTA Position: Q4 2025 in Review

Boothbay Fund Management sold out of Prothena Corp (PRTA) in Q4 2025, closing a stake of 30,000 shares — an estimated $293K sold.

Boothbay Fund Management first reported a position in PRTA in Q1 2019 and held it in 5 quarters. The position peaked at $1.5M in Q4 2020. 181 funds tracked by Wall St. Rank hold PRTA as of Q4 2025.

  • Boothbay Fund Management reported no remaining Prothena Corp position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 30,000 Prothena Corp shares in Q4 2025, an estimated $293K.
  • Boothbay Fund Management first reported a position in Prothena Corp in Q1 2019 and held it in 5 quarters.
  • Boothbay Fund Management's Prothena Corp position peaked at $1.5M in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.